Cargando…
Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the l...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128573/ https://www.ncbi.nlm.nih.gov/pubmed/21619573 http://dx.doi.org/10.1186/1471-2458-11-400 |
_version_ | 1782207451174535168 |
---|---|
author | Michel, Laurent Jauffret-Roustide, Marie Blanche, Jerôme Maguet, Olivier Calderon, Christine Cohen, Julien Carrieri, Patrizia M |
author_facet | Michel, Laurent Jauffret-Roustide, Marie Blanche, Jerôme Maguet, Olivier Calderon, Christine Cohen, Julien Carrieri, Patrizia M |
author_sort | Michel, Laurent |
collection | PubMed |
description | BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines. METHODS: A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively. RESULTS: A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed. CONCLUSIONS: A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions. |
format | Online Article Text |
id | pubmed-3128573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31285732011-07-02 Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy Michel, Laurent Jauffret-Roustide, Marie Blanche, Jerôme Maguet, Olivier Calderon, Christine Cohen, Julien Carrieri, Patrizia M BMC Public Health Research Article BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines. METHODS: A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively. RESULTS: A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed. CONCLUSIONS: A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions. BioMed Central 2011-05-27 /pmc/articles/PMC3128573/ /pubmed/21619573 http://dx.doi.org/10.1186/1471-2458-11-400 Text en Copyright ©2011 Michel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Michel, Laurent Jauffret-Roustide, Marie Blanche, Jerôme Maguet, Olivier Calderon, Christine Cohen, Julien Carrieri, Patrizia M Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title | Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title_full | Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title_fullStr | Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title_full_unstemmed | Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title_short | Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy |
title_sort | limited access to hiv prevention in french prisons (anrs pri(2)de): implications for public health and drug policy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128573/ https://www.ncbi.nlm.nih.gov/pubmed/21619573 http://dx.doi.org/10.1186/1471-2458-11-400 |
work_keys_str_mv | AT michellaurent limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT jauffretroustidemarie limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT blanchejerome limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT maguetolivier limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT calderonchristine limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT cohenjulien limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy AT carrieripatriziam limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy |